These results suggested that RRFBs might ameliorate BLM‐induced oxidative stress by up‐regulating Nrf2 expression and activating downstream genes (HO‐1/NQO1), contributing to the mitigation of PF. The gene discussed is HMOX1; the disease is Bloom syndrome.